Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor cells with the ability to proliferate without restraint, to invade through tissue boundaries, and to survive in foreign microenvironments. Recent studies have revealed that integrin signaling drives multiple stem cell functions, including tumor initiation, epithelial plasticity, metastatic reactivation, and resistance to oncogene- and immune-targeted therapies. Here, we discuss the mechanisms leading to the deregulation of integrin signaling in cancer and its various consequences. We place emphasis on novel functions, determinants of context dependency, and mechanism-based therapeutic opportunities.

[1]  M. Ewen,et al.  CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.

[2]  J. Qin,et al.  ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling. , 2012, Current opinion in cell biology.

[3]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[4]  Sercan Aksoy,et al.  Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer , 2020, Nature Communications.

[5]  A. Berns,et al.  NCAM‐induced focal adhesion assembly: a functional switch upon loss of E‐cadherin , 2008, The EMBO journal.

[6]  E. Fuchs,et al.  Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. , 2007, Cancer cell.

[7]  W. Muller,et al.  Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo , 2012, Breast Cancer Research.

[8]  Johanna Ivaska,et al.  Endosomes: Emerging Platforms for Integrin-Mediated FAK Signalling. , 2016, Trends in cell biology.

[9]  J. Visvader,et al.  Mammary stem cells and the differentiation hierarchy: current status and perspectives , 2014, Genes & development.

[10]  R. Jain,et al.  Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation , 2011, Proceedings of the National Academy of Sciences.

[11]  M. Mann,et al.  β1 integrin cytoplasmic tyrosines promote skin tumorigenesis independent of their phosphorylation , 2011, Proceedings of the National Academy of Sciences.

[12]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[13]  R. Weinberg,et al.  An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization. , 2013, Cancer cell.

[14]  M. Kris,et al.  Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.

[15]  Erik Sahai,et al.  Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling , 2015, Cancer cell.

[16]  Ricardo Garcia,et al.  Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis , 2011, Cell.

[17]  S. Courtneidge,et al.  The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.

[18]  M. Parsons,et al.  FAK-heterozygous mice display enhanced tumour angiogenesis , 2013, Nature Communications.

[19]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[20]  Francisco J. Sánchez-Rivera,et al.  Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival , 2017, Proceedings of the National Academy of Sciences.

[21]  F. Giancotti,et al.  Integrin β4 signaling promotes tumor angiogenesis , 2004 .

[22]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[23]  M. Wicha,et al.  Distinct FAK activities determine progenitor and mammary stem cell characteristics. , 2013, Cancer research.

[24]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[25]  Guanqing Ou,et al.  Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression , 2014, Nature Medicine.

[26]  Jenny G. Parvani,et al.  Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer. , 2015, Cancer research.

[27]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[28]  G. Inghirami,et al.  β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis , 2006, Cell.

[29]  J. Satagopan,et al.  β4 Integrin signaling induces expansion of prostate tumor progenitors. , 2013, The Journal of clinical investigation.

[30]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[31]  L. Shaw,et al.  Regulated splicing of the α6 integrin cytoplasmic domain determines the fate of breast cancer stem cells. , 2014, Cell reports.

[32]  E. Sahai,et al.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.

[33]  Howard Y. Chang,et al.  Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. , 2009, Cancer cell.

[34]  Guido Tarone,et al.  Positional control of cell fate through joint integrin/receptor protein kinase signaling. , 2003, Annual review of cell and developmental biology.

[35]  D. Schlaepfer,et al.  Focal adhesion kinase signaling in unexpected places. , 2017, Current opinion in cell biology.

[36]  D. Hardie.  The LKB1-AMPK pathway-friend or foe in cancer? , 2013, Cancer cell.

[37]  G. Thomas,et al.  High‐resolution in vivo imaging of breast cancer by targeting the pro‐invasive integrin αvβ6 , 2010, The Journal of pathology.

[38]  A. Burlingame,et al.  Discrete spatial organization of TGFβ receptors couples receptor multimerization and signaling to cellular tension , 2015, eLife.

[39]  Pang-Kuo Lo,et al.  CD49f and CD61 identify Her2/neu-induced mammary tumor initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling , 2011, Oncogene.

[40]  D. Sheppard,et al.  Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. , 2011, Cold Spring Harbor perspectives in biology.

[41]  T. Hagemann,et al.  Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread. , 2015, Cancer cell.

[42]  Michael S. Goldberg,et al.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice , 2018, Science.

[43]  P. Foubert,et al.  Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression. , 2011, Cancer cell.

[44]  David T. W. Jones,et al.  Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge , 2014, Nature Reviews Cancer.

[45]  S. Stilgenbauer,et al.  Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. , 2009, Blood.

[46]  Hwai-Shi Wang,et al.  CD44 Cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (αLβ2) and VLA-4 (α4β1) , 2005 .

[47]  Susan J Fisher,et al.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. , 2008, Molecular cell.

[48]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[49]  Z. Ronai,et al.  Emerging roles of ATF2 and the dynamic AP1 network in cancer , 2010, Nature Reviews Cancer.

[50]  R. Kaplan,et al.  KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis , 2017, Nature Medicine.

[51]  P. Carmeliet,et al.  A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours , 2011, Nature.

[52]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[53]  M. Perez-Moreno,et al.  Epithelial cell polarity, stem cells and cancer , 2011, Nature Reviews Cancer.

[54]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[55]  A. Mercurio,et al.  A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells , 2015, Genes & development.

[56]  Andrea I. McClatchey,et al.  Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship , 2014, Science Translational Medicine.

[57]  Jan Passchier,et al.  A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of 18F-FB-A20FMDV2 for Imaging the Integrin αvβ6 , 2018, The Journal of Nuclear Medicine Technology.

[58]  J. Massagué,et al.  Cell adhesion protein receptors as targets for transforming growth factor-β action , 1987, Cell.

[59]  K. Chan,et al.  Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma , 2016, Nature Communications.

[60]  T. Visakorpi,et al.  miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression. , 2015, Cancer research.

[61]  V. Quaranta,et al.  Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis , 2004, The Journal of cell biology.

[62]  Adam Byron,et al.  Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity , 2015, Cell.

[63]  E. Ruoslahti,et al.  Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.

[64]  E. Ruoslahti,et al.  αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF , 1997 .

[65]  Jieyu Wang,et al.  The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer , 2020, Cancer Cell International.

[66]  M. Rosenblum,et al.  Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization , 2018, Nature Cell Biology.

[67]  A. Shevchenko,et al.  β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. , 2012, The Journal of clinical investigation.

[68]  R. Weinberg,et al.  Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells , 2017, Proceedings of the National Academy of Sciences.

[69]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[70]  S. Cox,et al.  Cdc42 promotes transendothelial migration of cancer cells through β1 integrin , 2012, The Journal of cell biology.

[71]  R. Hynes,et al.  Changes in integrin receptors on oncogenically transformed cells , 1989, Cell.

[72]  Kyung-Han Lee,et al.  Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors , 2015, The Journal of Nuclear Medicine.

[73]  Gordon B Mills,et al.  Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. , 2012, Cancer cell.

[74]  R. Grosse,et al.  Nuclear Actin Network Assembly by Formins Regulates the SRF Coactivator MAL , 2013, Science.

[75]  B. Geiger,et al.  Dynamic regulation of the structure and functions of integrin adhesions. , 2013, Developmental cell.

[76]  William A. Flavahan,et al.  Periostin Secreted by Glioblastoma Stem Cells Recruits M2 Tumor-associated Macrophages and Promotes Malignant Growth , 2014, Nature Cell Biology.

[77]  A. Kabakov,et al.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy , 2020, Cells.

[78]  Adam Byron,et al.  Integrin ligands at a glance , 2006, Journal of Cell Science.

[79]  A. Mercurio,et al.  Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling , 2012, Journal of Cell Science.

[80]  Z. Werb,et al.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.

[81]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[82]  Antonio Rosato,et al.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth , 2015, Nature Cell Biology.

[83]  Catherine C. Park,et al.  β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. , 2013, Cancer research.

[84]  Pere Roca-Cusachs,et al.  Finding the weakest link – exploring integrin-mediated mechanical molecular pathways , 2012, Journal of Cell Science.

[85]  Kenneth M. Yamada,et al.  New dimensions in cell migration , 2012, Nature Reviews Molecular Cell Biology.

[86]  A. Krasnitz,et al.  DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. , 2008, Genes & development.

[87]  F. Sigaux,et al.  α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)* , 2012, The Journal of Biological Chemistry.

[88]  J. Gribben,et al.  Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy , 2014, Nature.

[89]  Jonathan A. Cooper,et al.  Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus , 2010, Cell.

[90]  M. Sixt,et al.  Rapid leukocyte migration by integrin-independent flowing and squeezing , 2008, Nature.

[91]  Jean Paul Thiery,et al.  EMT: 2016 , 2016, Cell.

[92]  P. Foubert,et al.  Integrin α4β1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis , 2010 .

[93]  M. Krause,et al.  Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells , 2016, Oncogene.

[94]  S. Tavazoie,et al.  Identification of Molecular Determinants of Primary and Metastatic Tumor Re-Initiation in Breast Cancer , 2015, Nature Cell Biology.

[95]  R. Weinberg,et al.  Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs , 2009, Proceedings of the National Academy of Sciences.

[96]  Fatima Al-Shahrour,et al.  In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. , 2013, Cancer cell.

[97]  Christoph Dieterich,et al.  Mechanical regulation of transcription controls Polycomb-mediated gene silencing during lineage commitment , 2016, Nature Cell Biology.

[98]  S. Vandenberg,et al.  PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes , 2013, Proceedings of the National Academy of Sciences.

[99]  J. Schwarzbauer,et al.  Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. , 2002, Molecular biology of the cell.

[100]  Arnoud Sonnenberg,et al.  Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice. , 2011, The Journal of clinical investigation.

[101]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[102]  S. Bicciato,et al.  The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.

[103]  Richard O Hynes,et al.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.

[104]  Edi Brogi,et al.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.

[105]  Kwok-Kin Wong,et al.  A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway , 2013, Nature Cell Biology.

[106]  R. Weinberg,et al.  Emerging Biological Principles of Metastasis , 2017, Cell.

[107]  E. Fuchs,et al.  Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling , 2011, Proceedings of the National Academy of Sciences.

[108]  J. Degen,et al.  Hemostatic factors, innate immunity and malignancy. , 2012, Thrombosis research.

[109]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[110]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[111]  Richard O Hynes,et al.  The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. , 2012, Cancer discovery.

[112]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[113]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[114]  D. Schlaepfer,et al.  Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.

[115]  M. Ginsberg,et al.  Talin and kindlin: the one-two punch in integrin activation , 2014, Frontiers of Medicine.

[116]  J. Norman,et al.  Mutant p53 Drives Invasion by Promoting Integrin Recycling , 2009, Cell.

[117]  O. Witte,et al.  Stem cells in prostate cancer initiation and progression. , 2007, The Journal of clinical investigation.

[118]  Z. Werb,et al.  Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.

[119]  Julie A. Wilkins,et al.  Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. , 2010, Developmental cell.

[120]  Jun Zhang,et al.  Functional Passenger-Strand miRNAs in Exosomes Derived from Human Colon Cancer Cells and Their Heterogeneous Paracrine Effects , 2020, International journal of biological sciences.

[121]  M. Davidson,et al.  The cancer glycocalyx mechanically primes integrin-mediated growth and survival , 2014, Nature.

[122]  H. Hibshoosh,et al.  PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion , 2015, Science Signaling.

[123]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[124]  S. Hilsenbeck,et al.  β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib , 2011, Breast Cancer Research.

[125]  Bob van de Water,et al.  β1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGFβ–miR-200–ZEB Network in E-Cadherin–Positive Triple-Negative Breast Cancer , 2014, Science Signaling.

[126]  Yarong Wang,et al.  Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA. , 2015, Cancer discovery.

[127]  R. Fässler,et al.  Integrin-mediated mechanotransduction , 2016, The Journal of cell biology.

[128]  F. Giancotti.  Targeting integrin β4 for cancer and anti-angiogenic therapy , 2007 .

[129]  Karl-Heinz Krause,et al.  Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. , 2017, Cancer cell.

[130]  Nam‐Gyun Kim,et al.  Adhesion to fibronectin regulates Hippo signaling via the FAK–Src–PI3K pathway , 2015, The Journal of cell biology.

[131]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[132]  I. Wistuba,et al.  RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas. , 2013, Cancer discovery.

[133]  R. Assoian,et al.  Growth control by intracellular tension and extracellular stiffness. , 2008, Trends in cell biology.

[134]  W. Gerald,et al.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. , 2009, The Journal of clinical investigation.

[135]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[136]  C. Chuah,et al.  CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. , 2016, Cancer cell.

[137]  J. Dennis,et al.  JCB_200811059 381..386 , 2009 .

[138]  T. Liang,et al.  Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. , 2017, Cancer research.

[139]  F. Giancotti,et al.  EGF-R signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes , 2001, The Journal of Cell Biology.

[140]  A. Álvarez-Buylla,et al.  A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma , 2018, Nature Cell Biology.

[141]  J. Massagué,et al.  Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. , 2011, Cancer cell.

[142]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[143]  P. Heikkilä,et al.  Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. , 2010, The American journal of pathology.

[144]  Jonathan A. Cooper,et al.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. , 2014, Cancer cell.

[145]  C. Marshall,et al.  The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. , 2010, Current opinion in cell biology.

[146]  M. Piskacek,et al.  The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases , 2018, Science Signaling.

[147]  C. Caldas,et al.  The Extracellular Matrix Protein TGFBI Induces Microtubule Stabilization and Sensitizes Ovarian Cancers to Paclitaxel , 2007, Cancer cell.

[148]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[149]  Mina J. Bissell,et al.  The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.

[150]  J. Shendure,et al.  Substantial inter-individual and limited intra-individual genomic diversity among tumors from men with metastatic prostate cancer , 2016, Nature Medicine.

[151]  M. Humphries,et al.  Synergistic control of cell adhesion by integrins and syndecans , 2007, Nature Reviews Molecular Cell Biology.

[152]  David C. Smith,et al.  Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.

[153]  I. Jurisica,et al.  Integrin α11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells , 2007, Proceedings of the National Academy of Sciences.

[154]  F. Watt,et al.  An activating beta1 integrin mutation increases the conversion of benign to malignant skin tumors. , 2009, Cancer research.

[155]  N. Zeleznik-Le,et al.  FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells. , 2015, Cell reports.

[156]  D. Weaver,et al.  Targeting Focal Adhesion Kinase Renders Pancreatic Cancers Responsive to Checkpoint Immunotherapy , 2016, Nature Medicine.

[157]  K. Aldape,et al.  Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. , 2014, The Lancet. Oncology.

[158]  D. Radisky,et al.  MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of αv and β3 Integrin Subunits , 2012, Nature Cell Biology.

[159]  Raghu Kalluri,et al.  VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization , 2011, Proceedings of the National Academy of Sciences.

[160]  M. Humphries,et al.  KANK2 Links αVβ5 Focal Adhesions to Microtubules and Regulates Sensitivity to Microtubule Poisons and Cell Migration , 2020, Frontiers in Cell and Developmental Biology.

[161]  S. Huh,et al.  Tumor and Stem Cell Biology Cancer Research Transiently Entrapped Circulating Tumor Cells Interact with Neutrophils to Facilitate Lung Metastasis Development , 2010 .

[162]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[163]  L. Ricci-Vitiani,et al.  Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma. , 2017, Cell stem cell.

[164]  M. Hemler,et al.  Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. , 2010, Cancer Research.

[165]  Yosef Yarden,et al.  Feedback regulation of EGFR signalling: decision making by early and delayed loops , 2011, Nature Reviews Molecular Cell Biology.

[166]  Martin L. Miller,et al.  Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma. , 2016, Cancer discovery.

[167]  M. Hemler.  Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. , 2003, Annual review of cell and developmental biology.

[168]  Srikanth K. Iyer,et al.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. , 2011, The Journal of clinical investigation.

[169]  L. Trusolino,et al.  A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth , 2001, Cell.

[170]  J. Massagué,et al.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. , 2011, Cancer cell.

[171]  Donald R Schwartz,et al.  Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. , 2003, Cancer cell.

[172]  Mikala Egeblad,et al.  Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.

[173]  Jiri Bartek,et al.  Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth , 2012, The Journal of experimental medicine.

[174]  E Ruoslahti,et al.  Integrin signaling. , 1999, Science.

[175]  C. Rueden,et al.  Bmc Medicine Collagen Density Promotes Mammary Tumor Initiation and Progression , 2022 .

[176]  Sarat Chandarlapaty,et al.  Negative feedback and adaptive resistance to the targeted therapy of cancer. , 2012, Cancer discovery.

[177]  A. Sonnenberg,et al.  Dual Role of α6β4 Integrin in Epidermal Tumor Growth: Tumor-suppressive Versus Tumor-promoting Function , 2007 .

[178]  R. Hynes,et al.  Tumor Angiogenesis in the Absence of Fibronectin or Its Cognate Integrin Receptors , 2015, PloS one.

[179]  F. Giancotti.  Mechanisms Governing Metastatic Dormancy and Reactivation , 2013, Cell.

[180]  Kenneth M. Yamada,et al.  Fibronectin, integrins, and growth control , 2001, Journal of cellular physiology.

[181]  J. Massagué,et al.  Contextual determinants of TGFβ action in development, immunity and cancer , 2018, Nature Reviews Molecular Cell Biology.

[182]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[183]  G. Scita,et al.  Pro‐migratory and TGF‐β‐activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8‐dependent GTPase switch , 2017, The Journal of pathology.

[184]  Jing Wang,et al.  An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition , 2014, Nature Cell Biology.

[185]  A. von Kriegsheim,et al.  RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1–IQGAP1 complex , 2013, The Journal of cell biology.

[186]  S. Grant,et al.  Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. , 2004, Genes & development.

[187]  A. Harris,et al.  Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF. , 2010, The American journal of pathology.

[188]  Xiaoyuan Chen,et al.  Clinical Translation of a Dual Integrin αvβ3– and Gastrin-Releasing Peptide Receptor–Targeting PET Radiotracer, 68Ga-BBN-RGD , 2017, The Journal of Nuclear Medicine.

[189]  R. McLendon,et al.  Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.

[190]  A. Chenn,et al.  Leukaemia hijacks a neural mechanism to invade the central nervous system , 2018, Nature.

[191]  M. Schmid.  PI3Kalpha activates integrin alpha4beta1 to establish a metastatic niche in lymph nodes , 2013 .

[192]  H. Frierson,et al.  Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model , 2009, Molecular Cancer Therapeutics.

[193]  L. Shaw,et al.  GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation , 2013, EMBO molecular medicine.

[194]  J. McGrath,et al.  Kindlin-1 controls Wnt and TGF-β availability to regulate cutaneous epithelial stem cell proliferation , 2014, Nature Medicine.

[195]  Arnoud Sonnenberg,et al.  Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing , 2010, EMBO reports.

[196]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[197]  H. Chapman,et al.  Urokinase receptor and integrin interactions. , 2003, Current pharmaceutical design.

[198]  A. Varki,et al.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. , 1999, The American journal of pathology.

[199]  E. Fuchs,et al.  Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival , 1996, The Journal of cell biology.

[200]  M. Wicha,et al.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. , 2009, Cancer research.

[201]  Daniel G. Anderson,et al.  Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice , 2014, Nature Communications.

[202]  Elaine Fuchs,et al.  Asymmetric cell divisions promote stratification and differentiation of mammalian skin , 2005, Nature.

[203]  C. Carman,et al.  Structural basis of integrin regulation and signaling. , 2007, Annual review of immunology.

[204]  F. Giancotti,et al.  Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin β4 cytoplasmic domain , 1998 .

[205]  S. Carr,et al.  Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters , 2014, eLife.

[206]  M. Ginsberg,et al.  Integrin‐associated proteins as potential therapeutic targets , 2008, Immunological reviews.

[207]  J. Thiery,et al.  β1 Integrin deletion from the basal compartment of the mammary epithelium affects stem cells , 2008, Nature Cell Biology.

[208]  R. Drapkin,et al.  Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. , 2016, JCI insight.

[209]  Kenneth M. Yamada,et al.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.

[210]  K. Ley,et al.  Integrin-based therapeutics : biological basis , clinical use and new drugs , 2016 .

[211]  Jenny G. Parvani,et al.  Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β , 2013, Molecular biology of the cell.

[212]  D. Cheresh,et al.  Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary gland. , 2014, Developmental cell.

[213]  F. Giancotti,et al.  Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane , 2005, The Journal of cell biology.

[214]  M. Schwartz.  Integrins, Oncogenes, and Anchorage Independence , 1997, The Journal of cell biology.

[215]  F. Giancotti,et al.  Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells , 1990, Cell.

[216]  J. Norman,et al.  Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors , 2009, Nature Medicine.

[217]  B. Turk,et al.  An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential. , 2014, Molecular cell.

[218]  D. Woods,et al.  Induction of β3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf–MEK–Extracellular Signal-Regulated Kinase Signaling Pathway , 2001, Molecular and Cellular Biology.

[219]  Daniel Benten,et al.  Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells , 2011, Hepatology.

[220]  M. Parsons,et al.  Endothelial FAK is required for tumour angiogenesis , 2010, EMBO molecular medicine.

[221]  Patricia J Keely,et al.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. , 2011, Cold Spring Harbor perspectives in biology.

[222]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[223]  J. Godet,et al.  Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. , 2012, Cancer research.

[224]  H. Beug,et al.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis , 2003, Nature Reviews Molecular Cell Biology.

[225]  F. Giancotti,et al.  Complexity and specificity of integrin signalling , 2000, Nature Cell Biology.

[226]  T. Pandita,et al.  β1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination , 2018, Molecular and Cellular Biology.

[227]  Kitty Tang,et al.  ERK and MMPs sequentially regulate distinct stages of epithelial tubule development. , 2004, Developmental cell.

[228]  R. Cardiff,et al.  Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression , 2007, Proceedings of the National Academy of Sciences.

[229]  S. Solomon,et al.  Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis , 2018, The New England journal of medicine.

[230]  Yu Xin Wang,et al.  Fibronectin regulates Wnt7a signaling and satellite cell expansion. , 2013, Cell stem cell.

[231]  S. Robinson,et al.  The role of β3-integrins in tumor angiogenesis: context is everything. , 2011, Current opinion in cell biology.

[232]  R. Weinberg,et al.  The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. , 2012, Cancer discovery.

[233]  Young Lim Choi,et al.  Transforming mutations of RAC guanosine triphosphatases in human cancers , 2013, Proceedings of the National Academy of Sciences.

[234]  R. Treisman,et al.  Actin Dynamics Control SRF Activity by Regulation of Its Coactivator MAL , 2003, Cell.

[235]  Chuong D. Hoang,et al.  A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. , 2013, Cancer cell.

[236]  Ben S. Wittner,et al.  Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells , 2014, Cell reports.